Simmons First Trust’s Gilead Sciences GILD Stock Holding History

Simmons First Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$2.19M	Buy	+21,673	New	+$2.26M	0.25%	86

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Simmons First Trust's GILD Position: Q4 2015 in Review

Simmons First Trust opened a new position in Gilead Sciences (GILD) in Q4 2015: 21,673 shares worth $2.19M. The stake represents 0.25% of the portfolio and ranks #86 among its holdings.

1,627 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

Simmons First Trust held 21,673 shares of Gilead Sciences worth $2.19M as of Q4 2015.
Gilead Sciences was a new Simmons First Trust position in Q4 2015.
Gilead Sciences made up 0.25% of Simmons First Trust's portfolio in Q4 2015, its #86 holding.
1,627 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Simmons First Trust's 13F filing for Q4 2015, filed 1 Feb 2016.